FERREX 150 PLUS- iron, ascorbic acid and succinic acid capsule 
Breckenridge Pharmaceutical, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Supplement Facts
*
Daily Value not established
Serving Size: 1 Capsule
Amount Per Serving% Daily Value
Iron (elemental)150 mg833%
  (33% as ferrous asparto glycinate and 67% as polysaccharide iron complex)
Vitamin C50 mg83%
  (81% and 1% as ascorbic acid and threonic acid)
Succinic Acid50 mg*

Inactive Ingredients

Gelatin, Crospovidone, Stearic Acid, Croscarmellose Sodium, Citric Acid, Microcrystalline Cellulose, Polyethylene Glycol, Titanium Dioxide, Polyvinylpyrrolidone, 1FD&C Yellow No. 6 Lake, Silica and FD&C Red No. 40 Lake

1
This product contains FD&C Yellow No. 6 Lake as a color additive.

If pregnant or breast-feeding, ask a health professional before use.

DOSAGE AND ADMINISTRATION

Adults take 1 or 2 capsules daily, or as directed by a physician.

WARNING

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Iron is best absorbed on an empty stomach; however, occasional gastrointestinal discomfort (such as nausea) may be minimized by taking with meals. Iron-containing medication may occasionally cause black stools, constipation, or diarrhea, which is usually transient and self-limiting.

How Supplied

Ferrex™ 150 Plus is supplied as an orange and white capsule, imprinted "B703", NDC # 51991-703-90

Store at 25°C (77°F); excursions permitted to 15° - 30°C (59° - 86°F).
See USP Controlled Room Temperature.
Protect from light and moisture.

Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP/NF.

Warning: Keep this and all medications out of the reach of children.

All prescription substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

Distributed by:
Breckenridge Pharmaceutical, Inc.
Boca Raton, FL 33487

To report a serious
adverse event contact:
1-800-367-3395

Manufactured by:
Contract Pharmacal Corp.
Hauppauge, NY 11788 USA

Rev. 04/09

PRINCIPAL DISPLAY PANEL - Capsule Bottle

Breckenridge
Pharmaceutical, Inc.

NDC 51991-703-90

Ferrex™ 150 Plus
Capsules

Do not use if the safety seal under
the cap is broken or missing.

Dietary Supplement

90 CAPSULES

PRINCIPAL DISPLAY PANEL - Capsule Bottle
FERREX 150 PLUS 
iron, ascorbic acid, and succinic acid capsule
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51991-703
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Iron (Iron) Iron150 mg
Ascorbic Acid (Ascorbic Acid) Ascorbic Acid50 mg
Succinic Acid (Succinic Acid) Succinic Acid50 mg
Inactive Ingredients
Ingredient NameStrength
Gelatin 
Crospovidone 
Stearic Acid 
Croscarmellose Sodium 
Citric Acid Monohydrate 
Cellulose, Microcrystalline 
Polyethylene Glycols 
Titanium Dioxide 
FD&C Yellow no. 6 
Silicon Dioxide 
FD&C Red no. 40 
Aluminum Oxide 
Product Characteristics
ColorORANGE, WHITEScoreno score
ShapeCAPSULESize22mm
FlavorImprint Code B703
Contains    
Packaging
#Item CodePackage Description
1NDC:51991-703-9090 in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other09/30/200912/31/2012
Labeler - Breckenridge Pharmaceutical, Inc. (150554335)
Establishment
NameAddressID/FEIBusiness Operations
Contract Pharmacal Corporation057795122MANUFACTURE(51991-703)

Revised: 03/2013
Document Id: 13c1a138-5829-4f75-bd93-645f5e88d57a
Set id: d9bba3c3-98bf-4227-ab9c-c1a3d0ee384c
Version: 3
Effective Time: 20130320
 
Breckenridge Pharmaceutical, Inc.